Natural Compounds in Disease Treatment
Natural Compounds in Disease Treatment is a research topic within Complementary and alternative medicine. Science Explorer counts 4.9k research works in it since 1951. 29.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the therapeutic potential of herbal medicines, focusing on compounds such as Celastrol and Triptolide derived from Thunder God Vine and Tripterygium wilfordii Hook F. The research covers their applications in treating inflammatory disorders, cancer, and neurodegenerative diseases, as well as their potential in targeting specific pathways like NF-?B, inducing apoptosis, and acting as antioxidants. Additionally, the cluster delves into the use of these herbal medicines in conditions like rheumatoid arthritis through drug targeting approaches.
- Celastrol
- Triptolide
- Traditional Medicines
- Inflammatory Disorders
- Cancer Treatment
- NF-?B Inhibition
- Apoptosis Induction
- Antioxidant Activity
- Rheumatoid Arthritis
- Drug Targeting
- Research works
- 4.9k fractional, since 1951
- In the world top 10%
- 1.4k per year above
- Top-10% rate
- 29.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +12% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Natural Compounds in Disease Treatment research?
By volume, China and India publish the most (587 and 55 works in 2022–2025).
By volume, 2022–2025
- 1 China 587 works
- 2 India 55 works
- 3 United States 42 works
- 4 Brazil 22 works
- 5 South Korea 17 works
- 6 Egypt 17 works
- 7 Iran 16 works
- 8 Japan 13 works
- 9 Saudi Arabia 12 works
- 10 Türkiye 10 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Natural Compounds in Disease Treatment research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Natural Compounds in Disease Treatment research, followed by Nanjing University of Chinese Medicine and China Pharmaceutical University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 17 works
- 2 Nanjing University of Chinese MedicineChina 15 works
- 3 China Pharmaceutical UniversityChina 10 works
- 4 Beijing University of Chinese MedicineChina 10 works
- 5 Zhejiang Chinese Medical UniversityChina 9 works
- 6 First Affiliated Hospital of Henan UniversityChina 8 works
- 7 Anhui University of Traditional Chinese MedicineChina 6 works
- 8 Chengdu University of Traditional Chinese MedicineChina 6 works
- 9 Shanghai University of Traditional Chinese MedicineChina 6 works
- 10 Guangzhou University of Chinese MedicineChina 5 works
Where is Natural Compounds in Disease Treatment research done?
The largest centres of Natural Compounds in Disease Treatment research in 2022–2025 are Beijing (China), Nanjing (China), Guangzhou (China) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Hangzhou and Nanjing.
Largest cities, 2022–2025
Where it is the local speciality
- HangzhouCN · 27.1 works4.6×
- NanjingCN · 39.6 works4.4×
Location quotient: how much more of its research is in Natural Compounds in Disease Treatment than the world average.
Where is the best place to study Natural Compounds in Disease Treatment?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing University of Chinese Medicine and Nanjing University of Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 64.3 | 47.0% | 20.3× | 17 | +88.0% |
| 2 | Beijing University of Chinese MedicineChina | 51.9 | 50.5% | 62.3× | 10 | +168.7% |
| 3 | Nanjing University of Chinese MedicineChina | 36.0 | 39.1% | 68.2× | 15 | +5.9% |
| 4 | China Pharmaceutical UniversityChina | 35.7 | 46.8% | 50.7× | 10 | -10.8% |
| 5 | Zhejiang Chinese Medical UniversityChina | 2.6 | 27.1% | 38.5× | 9 | -26.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Natural Compounds in Disease Treatment research growing?
Output in 2018–2022 was 12% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Natural Compounds in Disease Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.